About the BioAsia Group
On behalf of the BioAsia team, it is a great honor to welcome you to attend the eighth edition of BioAsia: The Global Biobusiness forum, which will be held... more »
Have something to say?
Join LinkedIn for free to participate in the conversation. When you join, you can comment and post your own discussions.
Join LinkedInMost Popular Discussions

Rick is based in Shanghai, China to help establish the Anti-infective (AI) Research unit. He previously headed up the External Research Solutions Center of Emphasis (ERS COE) that managed the network of pre-clinical contract research organizations supporting Pfizer Research. This network comprises the external Chemistry, Biology, drug metabolism and material management providers for the [...]

Your Gateway to BioAsia 2012 is just a click away! Check out our new website
Your gateway to the most happening global lifesciences event, BioAsia 2012 is just a click away! Check out our new website to explore ...
http://bioasia.in/emailer/emailer-04.html 2012.bioasia.in

ProQinase covers all aspects of protein kinase targeted drug development. kinase assays and angiogenesis assays are a special focus of the service portfolio.

With a noticeable difference, BioAsia 2012 will not only provide an opportunity to connect with the key stakeholders across categories, but will also provide a platform to outline a roadmap for growth through the planned...

Masterclass on Developing an effective CIP and Cleaning Validation Program for FDA/EU Compliance
CIP and Cleaning Validation Masterclass at BioAsia 2012 will be one of its kind platform to learn, share & take away practical ...
Only 30 seats available! Register now! For more information or registration contact: Ms. Paridhi Gupta paridhi@biofaba.org +91-40-6644 6477/6577

Global Thought Leaders at BioAsia 2012, Hyderabad, India.
Look forward to a wide range of exciting prospects in BioAsia 2013.
bioasia.in bioasia.in

BioAsia is now an open group
I am pleased to announce that, as the owner of this group, I have just switched us to an open discussion group. All future discussions ...

BioAsia 2012 Blog
Patentability of Biotechnological Inventions
Patentability of Biotechnological Inventions bioasia.in
TRIPS (trade-related aspects of intellectual property rights) requires that patents be available in all areas of technology ( Art. 27(1)) which includes biotechnology. However, TRIPS allow exceptions from patentability for the protection of ‘‘ordre public or morality’’ (Art. 27(2).) plants and animals, essentially biological processes for producing animals or plants, and methods for treating human

In continuation to my earlier post, I have attempted to touch upon the European Scenario on patentability of biotech innovations. In the EU, there is no unified law for patents; both the intergovernmental European Patent Convention (EPC) and national laws govern. The EPC provides for a centralized search and examination process by the EPO, which [...]

Hiring for the Biotech sector is perceived as a huge challenge. The gap between Industry needs and Academic training has been the scapegoat on various HR forums in this Industry. Moreover, frustration, stemming from the immense hype created over the past 10 years, and the disconnect with the ground reality of educated unemployed, has caused [...]

Earlier during the end of last year and earlier this year, I made a couple of trips to India. First one was with Jim Miller, President, Pharm Source, an industry expert on Pharma Outsourcing and an accurate Outsourcing dash board commenter on developing trends in Global outsourcing. The second visit was with Dr. David Lyon [...]

Dr. Richard D. Connell adds up to the list of outstanding speakers that will make a mark in the ninth edition of BioAsia i.e. BioAsia 2012: The Global Biobusiness Forum. Rick is based in Shanghai, China to help establish the Anti-infective (AI) Research unit. He previously headed up the External Research Solutions Center of Emphasis (ERS [...]

Dr. Hasit Joshipura is a graduate in Electrical Engineering from VJTI - Bombay University and a Post Graduate from Indian Institute of Management - Ahmedabad. He has completed his Doctorate programme at the School of Management at IIT Mumbai. After having spent about three years with the Tata Administrative Services, [...]

Antibodies and light combine for a cancer-killing therapy arstechnica.com
An antibody, a light-sensitive chemical, and some near-infrared light have been combined to make a very specific cancer-killing compound.
